Rocket Pharmaceuticals Shares Rise After Needham Upgrade
MT newswire2026/09/16 18:09
02:09 PM EDT, 09/16/2026 (MT Newswires) -- Rocket Pharmaceuticals (RCKT) shares were up almost 2% in Wednesday trading after Needham upgraded the stock to buy from hold, with a price target of $9. Trading volume stood at more than 1.7 million shares, compared with a daily average of about 2 million. Price: 3.48, Change: +0.07, Percent Change: +1.91
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.